| |
| |
|
| Insider
Information: |
Dobmeier Eric |
| Relationship: |
President, CEO, Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
730,812 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$28,097,365 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
730,812 |
|
|
| Total
Value |
$28,097,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
13
|
3
|
|
Stock
price went up :
|
7
|
3
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.2
|
3.0
|
| Percentage
Gain/Loss : |
 18.2%
|
198.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
Chief Operating Officer |
2017-12-04 |
119,860 |
2004-05-05 |
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Director |
2017-06-19 |
27,963 |
|
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2023-11-10 |
563,325 |
2015-12-16 |
0 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
18,160 |
2017-05-25 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2021-02-14 |
1,504 |
2019-12-26 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
President, CEO, Director |
2023-08-11 |
0 |
2020-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2022-05-25 |
4 |
B |
$13.03 |
$65,148 |
D/D |
5,000 |
205,880 |
2.81 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2022-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,796 |
236,676 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2022-12-01 |
4 |
AS |
$22.31 |
$669,351 |
D/D |
(30,000) |
241,676 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2022-12-01 |
4 |
OE |
$0.42 |
$25,200 |
D/D |
60,000 |
271,676 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2022-12-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
211,676 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2022-12-14 |
4 |
OE |
$0.35 |
$10,500 |
D/D |
30,000 |
271,676 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-01-30 |
4 |
OE |
$0.42 |
$10,500 |
D/D |
25,000 |
296,676 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-01-30 |
4 |
AS |
$24.54 |
$613,613 |
D/D |
(25,000) |
271,676 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-01-31 |
4 |
AS |
$24.68 |
$189,757 |
D/D |
(7,688) |
288,987 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,999 |
296,675 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-02-10 |
4 |
S |
$23.75 |
$192,292 |
D/D |
(8,097) |
301,138 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,248 |
309,235 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-04-24 |
4 |
S |
$22.26 |
$26,711 |
D/D |
(1,200) |
301,138 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-04-24 |
4 |
AS |
$21.58 |
$513,528 |
D/D |
(23,800) |
302,338 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-04-24 |
4 |
OE |
$0.42 |
$10,500 |
D/D |
25,000 |
326,138 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
President, CEO |
• • – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(301,138) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
V. P., Corporate Affairs |
• – – |
2004-05-05 |
4 |
S |
$8.50 |
$128,875 |
D/D |
(15,000) |
300 |
|
- |
|
| SGEN |
Seagen Inc |
V. P., Corporate Affairs |
• – – |
2004-05-05 |
4 |
OE |
$2.77 |
$44,532 |
D/D |
15,000 |
2,800 |
|
- |
|
| SGEN |
Seagen Inc |
V. P., Corporate Affairs |
• – – |
2004-06-21 |
4 |
OE |
$5.25 |
$26,250 |
D/D |
5,000 |
5,300 |
|
- |
|
| SGEN |
Seagen Inc |
Sr. VP, Corporate Development |
• – – |
2007-02-09 |
4 |
S |
$8.90 |
$446,955 |
D/D |
(50,000) |
1,798 |
0 |
- |
|
| SGEN |
Seagen Inc |
Sr. VP, Corporate Development |
• – – |
2007-02-09 |
4 |
OE |
$2.70 |
$184,395 |
D/D |
43,472 |
5,198 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
OE |
$4.45 |
$213,389 |
D/D |
44,400 |
5,198 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
S |
$11.60 |
$128,384 |
D/D |
(11,000) |
3,798 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
OE |
$5.25 |
$57,750 |
D/D |
11,000 |
5,098 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
S |
$11.50 |
$512,167 |
D/D |
(44,400) |
3,798 |
0 |
- |
|
177 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
